Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.11.2019TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)43180Methotrexate-Teva 2,5 mg, tablety (tbl 100x2,5 mg (fľ.PE))29.11.2019O
 20.11.2019Actavis Group PTC ehf. (ACT-5)54433Bicusan 150 mg (tbl flm 30x150 mg (blis.PVC/PE/PVDC/Al))28.2.2020Z
 20.11.2019Janssen - Cilag International N.V. (JNS)6346ASTAYVEER 62,5 mg filmom obalené tablety (tbl flm 56x62,5 mg (blis.PVC/PE/PVDC/Al))1.2.2020Z
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)05193Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok (sol ijf 1x20 ml/1 g (liek.inj.skl.))22.11.2019R
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)05194Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok (sol ijf 1x100 ml/5 g (liek.inj.skl.))19.11.2019R
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)5715ACytarabine Accord 100 mg/ml injekčný a infúzny roztok (sol ijf 1x1 ml (liek.inj.skl.))14.11.2019O
 19.11.2019Janssen Biologics B.V. (JAN-NL)9392ASimponi 100 mg injekčný roztok naplnený v injekčnom pere (sol ira 1x1 ml/100 mg (pero napl.skl. - SmartJect))31.1.2020Z
 19.11.2019Upjohn EESV (UPO-NL)83540ZOLOFT 50 mg (tbl flm 28x50 mg (blis.Al/PVC))19.11.2019O
 19.11.2019Pfizer Europe MA EEIG (PFI-BE-3)62362DALACIN V 2 % (crm vag 1x40 g (tuba PE))19.11.2019O
 19.11.2019TS Pharma s.r.o. (TPH-1)37388Tarka 240 mg/4 mg tablety (tbl flm 56x240 mg/4 mg (blis.PVC/PVDC/Al))20.11.2019O
 19.11.2019Mylan Ireland Limited (MNY)05617Rizatriptan Mylan 10 mg (tbl oro 6x10 mg (blis.OPA/Al/PVC))20.11.2019R
 19.11.2019Mylan Ireland Limited (MNY)0877APerindopril Mylan 4 mg (tbl 30x4 mg (blis.Al/OPA/PVC/Al))31.12.2019Z
 19.11.2019Mylan Ireland Limited (MNY)5331CAripiprazol Mylan 10 mg orodispergovateľné tablety (tbl oro 28x10 mg (blis.PA/Al/PVC/Al/papier/PET-perfor.))20.11.2019R
 18.11.2019Fresenius Medical Care Nephrologica Deutschland GmbH (FMC-2)39424Sorbisterit (plu pre 1x500 g (nád.PE))12.11.2019R
 18.11.2019Fresenius Medical Care Nephrologica Deutschland GmbH (FMC-2)46292OsvaRen (tbl flm 180)12.11.2019R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)